Crewe Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-4
Closed -$240 933
2023
Q4
$240 Hold
4
﹤0.01% 344
2023
Q3
$153 Buy
+4
New +$153 ﹤0.01% 471